Fecal microflora in a patient with short-bowel syndrome and identification of dominant lactobacilli.
Fecal microflora and lactate concentrations in blood and feces obtained from a patient (a 5 year-old boy) with short-bowel syndrome (SBS) were compared during acidosis to results for the normal condition (no SBS symptoms). The taxonomical position of the lactobacilli found predominantly in the feces sample obtained 2 days before the fifth attack was also studied. The D-lactate level in serum obtained 1 day after the fourth attack was 10-fold higher than that for the normal condition, although there was not a great difference in L-lactate levels. D-Lactate (3.91 mM) and L-lactate (2.86 mM) were also detected in the feces samples collected 2 days before the fifth attack, while no lactate was detected in the feces sample for the normal condition. The counts of total fecal bacteria, especially anaerobic bacteria such as members of the family Bacteroidaceae, were found to be low. The counts of lactobacilli and the total population of lactobacilli relative to total fecal bacteria in the feces 2 days before the fifth attack (40.4%) were extremely high. In this case, a majority of the lactobacilli were D-lactate producers as determined by homolactic fermentation. These lactobacilli were identified as Lactobacillus delbrueckii subsp. lactis. The percentages of bifidobacteria relative to total fecal bacteria in feces samples obtained both 2 days before the fifth attack (50.9%) and for normal condition (61.9%) were also high, although these bacteria were L-lactate producers. In the feces samples for the normal condition, the D-lactate producers decreased to less than 10(9) per g, while the counts of L- or DL-lactate producers were 100-fold higher than the numbers in feces samples obtained 2 days before the fifth attack. These results suggested that an increase in the level of D-lactate producers, such as L. delbrueckii subsp. lactis, in the colon may be associated with the clinical expression of metabolic acidosis.
Kaneko
T
T
Central Research Institute, Meiji Milk Products Co., Higashimurayama, Tokyo, Japan. microbio@ba2.so-net.or.jp
Bando
Y
Y
Kurihara
H
H
Satomi
K
K
Nonoyama
K
K
Matsuura
N
N
D000140:Acidosis, Lactic / Q000209:etiology / Q000378:metabolism / Q000382:microbiology; D001482:Base Composition; D001483:Base Sequence; D002675:Child, Preschool; D015169:Colony Count, Microbial; D017931:DNA Primers / Q000235:genetics; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification; D005232:Fatty Acids, Volatile / Q000097:blood / Q000378:metabolism; D005243:Feces / Q000737:chemistry / Q000382:microbiology*; D006801:Humans; D019344:Lactic Acid / Q000097:blood / Q000378:metabolism; D007778:Lactobacillus / Q000235:genetics / Q000302:isolation & purification* / Q000378:metabolism; D008297:Male; D016133:Polymerase Chain Reaction; D012778:Short Bowel Syndrome / Q000150:complications / Q000378:metabolism / Q000382:microbiology*
D017931:DNA Primers; D004269:DNA, Bacterial; D005232:Fatty Acids, Volatile; D019344:Lactic Acid